ReposiTrak (TRAK) director discloses stock compensation transaction
Rhea-AI Filing Summary
ReposiTrak, Inc. director Robert Allen reported receiving 1,265 shares of common stock on 11/05/2025. These shares were issued instead of cash payments for his service on the company’s Board of Directors for the quarter ended September 30, 2025.
After this transaction, he beneficially owned 199,147 shares of common stock directly, 587,476 shares indirectly through a trust, 2,775 shares indirectly through his spouse, and 39,704 shares of Series B preferred stock directly.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 1,265 | $0.00 | $0.00 |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Series B Preferred Stock | -- | -- | -- |
Footnotes (1)
- F1. Shares issued in lieu of amounts payable to the Reporting Person for his service on the Issuer's Board of Directors for the quarter ended September 30, 2025.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider transaction was reported for ReposiTrak (TRAK)?
Director Robert Allen reported receiving 1,265 shares of common stock on 11/05/2025, issued in lieu of cash fees for Board service.
What is Robert Allen’s total direct ReposiTrak common stock ownership after this transaction?
Following the reported transaction, Robert Allen directly beneficially owned 199,147 shares of ReposiTrak common stock.
What indirect holdings in ReposiTrak stock does Robert Allen report?
He reports indirect ownership of 587,476 common shares by a trust and 2,775 common shares by his spouse.
Does Robert Allen hold any ReposiTrak preferred stock?
Yes. He reports direct beneficial ownership of 39,704 shares of Series B preferred stock of ReposiTrak.
What is Robert Allen’s relationship to ReposiTrak?
He is identified as a Director of ReposiTrak, Inc. on the reported form.